▶ 調査レポート

世界のプラダーウィリー症候群治療薬市場規模・現状・予測(2021年-2027年)

• 英文タイトル:Global Prader-Willi Syndrome Therapeutics Market Size, Status and Forecast 2021-2027

QYResearchが調査・発行した産業分析レポートです。世界のプラダーウィリー症候群治療薬市場規模・現状・予測(2021年-2027年) / Global Prader-Willi Syndrome Therapeutics Market Size, Status and Forecast 2021-2027 / QYR2104Z4739資料のイメージです。• レポートコード:QYR2104Z4739
• 出版社/出版日:QYResearch / 2021年4月10日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、97ページ
• 納品方法:Eメール(納期:3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Multi User/Five User¥865,800 (USD5,850)▷ お問い合わせ
  Enterprise License(同一法人内共有可)¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYResearch社発行の本調査資料では、プラダーウィリー症候群治療薬のグローバル市場(2016年~2027年)について調べ、市場動向、主要企業の市場シェア、種類別市場規模(ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他)、用途別市場規模(診療所、病院、その他)、主要地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等)、関連企業情報などを掲載しています。
・市場概要
・プラダーウィリー症候群治療薬の市場動向
・企業の競争状況、市場シェア
・プラダーウィリー症候群治療薬の種類別市場規模(ベロラニブ、塩酸ベタヒスチン、ジアゾキシドコリンCR、FE-992097、NOX-B11、その他)
・プラダーウィリー症候群治療薬の用途別市場規模(診療所、病院、その他)
・プラダーウィリー症候群治療薬の北米市場規模2016-2027(アメリカ、カナダ)
・プラダーウィリー症候群治療薬のヨーロッパ市場規模2016-2027(ドイツ、フランス、イギリス等)
・プラダーウィリー症候群治療薬のアジア市場規模2016-2027(日本、中国、韓国、インド、東南アジア等)
・プラダーウィリー症候群治療薬の中南米市場規模2016-2027(メキシコ、ブラジル)
・プラダーウィリー症候群治療薬の中東・アフリカ市場規模2016-2027(トルコ、サウジアラビア等)
・主要企業情報(Chong Kun Dang Pharmaceutical Corp.、Essentialis, Inc.、Ferring International Center S.A.、LG Life Sciences, Ltd.、P2D Bioscience、Pfizer Inc.、Rhythm Pharmaceuticals)
・結論

Market Analysis and Insights: Global Prader-Willi Syndrome Therapeutics Market
The global Prader-Willi Syndrome Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Prader-Willi Syndrome Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Prader-Willi Syndrome Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Prader-Willi Syndrome Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Prader-Willi Syndrome Therapeutics market.

Global Prader-Willi Syndrome Therapeutics Scope and Market Size
Prader-Willi Syndrome Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Prader-Willi Syndrome Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Beloranib
Betahistine Hydrochloride
Diazoxide Choline CR
FE-992097
NOX-B11
Others

Segment by Application
Clinic
Hospital
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Chong Kun Dang Pharmaceutical Corp.
Essentialis, Inc.
Ferring International Center S.A.
LG Life Sciences, Ltd.
P2D Bioscience
Pfizer Inc.
Rhythm Pharmaceuticals

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Prader-Willi Syndrome Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Beloranib
1.2.3 Betahistine Hydrochloride
1.2.4 Diazoxide Choline CR
1.2.5 FE-992097
1.2.6 NOX-B11
1.2.7 Others
1.3 Market by Application
1.3.1 Global Prader-Willi Syndrome Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Prader-Willi Syndrome Therapeutics Market Perspective (2016-2027)
2.2 Prader-Willi Syndrome Therapeutics Growth Trends by Regions
2.2.1 Prader-Willi Syndrome Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Prader-Willi Syndrome Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Prader-Willi Syndrome Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Prader-Willi Syndrome Therapeutics Industry Dynamic
2.3.1 Prader-Willi Syndrome Therapeutics Market Trends
2.3.2 Prader-Willi Syndrome Therapeutics Market Drivers
2.3.3 Prader-Willi Syndrome Therapeutics Market Challenges
2.3.4 Prader-Willi Syndrome Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Prader-Willi Syndrome Therapeutics Players by Revenue
3.1.1 Global Top Prader-Willi Syndrome Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Prader-Willi Syndrome Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Prader-Willi Syndrome Therapeutics Revenue
3.4 Global Prader-Willi Syndrome Therapeutics Market Concentration Ratio
3.4.1 Global Prader-Willi Syndrome Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Prader-Willi Syndrome Therapeutics Revenue in 2020
3.5 Prader-Willi Syndrome Therapeutics Key Players Head office and Area Served
3.6 Key Players Prader-Willi Syndrome Therapeutics Product Solution and Service
3.7 Date of Enter into Prader-Willi Syndrome Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Prader-Willi Syndrome Therapeutics Breakdown Data by Type
4.1 Global Prader-Willi Syndrome Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Type (2022-2027)

5 Prader-Willi Syndrome Therapeutics Breakdown Data by Application
5.1 Global Prader-Willi Syndrome Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Prader-Willi Syndrome Therapeutics Market Size (2016-2027)
6.2 North America Prader-Willi Syndrome Therapeutics Market Size by Type
6.2.1 North America Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2027)
6.3 North America Prader-Willi Syndrome Therapeutics Market Size by Application
6.3.1 North America Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2027)
6.4 North America Prader-Willi Syndrome Therapeutics Market Size by Country
6.4.1 North America Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada

7 Europe
7.1 Europe Prader-Willi Syndrome Therapeutics Market Size (2016-2027)
7.2 Europe Prader-Willi Syndrome Therapeutics Market Size by Type
7.2.1 Europe Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2027)
7.3 Europe Prader-Willi Syndrome Therapeutics Market Size by Application
7.3.1 Europe Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2027)
7.4 Europe Prader-Willi Syndrome Therapeutics Market Size by Country
7.4.1 Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Type
8.2.1 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Application
8.3.1 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region
8.4.1 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Prader-Willi Syndrome Therapeutics Market Size (2016-2027)
9.2 Latin America Prader-Willi Syndrome Therapeutics Market Size by Type
9.2.1 Latin America Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Prader-Willi Syndrome Therapeutics Market Size by Application
9.3.1 Latin America Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Prader-Willi Syndrome Therapeutics Market Size by Country
9.4.1 Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Type
10.2.1 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Application
10.3.1 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country
10.4.1 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Chong Kun Dang Pharmaceutical Corp.
11.1.1 Chong Kun Dang Pharmaceutical Corp. Company Details
11.1.2 Chong Kun Dang Pharmaceutical Corp. Business Overview
11.1.3 Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Introduction
11.1.4 Chong Kun Dang Pharmaceutical Corp. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021)
11.1.5 Chong Kun Dang Pharmaceutical Corp. Recent Development
11.2 Essentialis, Inc.
11.2.1 Essentialis, Inc. Company Details
11.2.2 Essentialis, Inc. Business Overview
11.2.3 Essentialis, Inc. Prader-Willi Syndrome Therapeutics Introduction
11.2.4 Essentialis, Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021)
11.2.5 Essentialis, Inc. Recent Development
11.3 Ferring International Center S.A.
11.3.1 Ferring International Center S.A. Company Details
11.3.2 Ferring International Center S.A. Business Overview
11.3.3 Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Introduction
11.3.4 Ferring International Center S.A. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021)
11.3.5 Ferring International Center S.A. Recent Development
11.4 LG Life Sciences, Ltd.
11.4.1 LG Life Sciences, Ltd. Company Details
11.4.2 LG Life Sciences, Ltd. Business Overview
11.4.3 LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Introduction
11.4.4 LG Life Sciences, Ltd. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021)
11.4.5 LG Life Sciences, Ltd. Recent Development
11.5 P2D Bioscience
11.5.1 P2D Bioscience Company Details
11.5.2 P2D Bioscience Business Overview
11.5.3 P2D Bioscience Prader-Willi Syndrome Therapeutics Introduction
11.5.4 P2D Bioscience Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021)
11.5.5 P2D Bioscience Recent Development
11.6 Pfizer Inc.
11.6.1 Pfizer Inc. Company Details
11.6.2 Pfizer Inc. Business Overview
11.6.3 Pfizer Inc. Prader-Willi Syndrome Therapeutics Introduction
11.6.4 Pfizer Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021)
11.6.5 Pfizer Inc. Recent Development
11.7 Rhythm Pharmaceuticals
11.7.1 Rhythm Pharmaceuticals Company Details
11.7.2 Rhythm Pharmaceuticals Business Overview
11.7.3 Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Introduction
11.7.4 Rhythm Pharmaceuticals Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021)
11.7.5 Rhythm Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Prader-Willi Syndrome Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Beloranib
Table 3. Key Players of Betahistine Hydrochloride
Table 4. Key Players of Diazoxide Choline CR
Table 5. Key Players of FE-992097
Table 6. Key Players of NOX-B11
Table 7. Key Players of Others
Table 8. Global Prader-Willi Syndrome Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Prader-Willi Syndrome Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 10. Global Prader-Willi Syndrome Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 11. Global Prader-Willi Syndrome Therapeutics Market Share by Regions (2016-2021)
Table 12. Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 13. Global Prader-Willi Syndrome Therapeutics Market Share by Regions (2022-2027)
Table 14. Prader-Willi Syndrome Therapeutics Market Trends
Table 15. Prader-Willi Syndrome Therapeutics Market Drivers
Table 16. Prader-Willi Syndrome Therapeutics Market Challenges
Table 17. Prader-Willi Syndrome Therapeutics Market Restraints
Table 18. Global Prader-Willi Syndrome Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 19. Global Prader-Willi Syndrome Therapeutics Market Share by Players (2016-2021)
Table 20. Global Top Prader-Willi Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prader-Willi Syndrome Therapeutics as of 2020)
Table 21. Ranking of Global Top Prader-Willi Syndrome Therapeutics Companies by Revenue (US$ Million) in 2020
Table 22. Global 5 Largest Players Market Share by Prader-Willi Syndrome Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 23. Key Players Headquarters and Area Served
Table 24. Key Players Prader-Willi Syndrome Therapeutics Product Solution and Service
Table 25. Date of Enter into Prader-Willi Syndrome Therapeutics Market
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 28. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type (2016-2021)
Table 29. Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 30. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 31. Global Prader-Willi Syndrome Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 32. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Application (2016-2021)
Table 33. Global Prader-Willi Syndrome Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 34. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 35. North America Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 36. North America Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 37. North America Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 38. North America Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 39. North America Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 40. North America Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 41. Europe Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 42. Europe Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 43. Europe Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 44. Europe Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 45. Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 46. Europe Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 48. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 50. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 51. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 52. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 53. Latin America Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 54. Latin America Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 55. Latin America Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 56. Latin America Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 57. Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 58. Latin America Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 60. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 62. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 63. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 64. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 65. Chong Kun Dang Pharmaceutical Corp. Company Details
Table 66. Chong Kun Dang Pharmaceutical Corp. Business Overview
Table 67. Chong Kun Dang Pharmaceutical Corp. Prader-Willi Syndrome Therapeutics Product
Table 68. Chong Kun Dang Pharmaceutical Corp. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 69. Chong Kun Dang Pharmaceutical Corp. Recent Development
Table 70. Essentialis, Inc. Company Details
Table 71. Essentialis, Inc. Business Overview
Table 72. Essentialis, Inc. Prader-Willi Syndrome Therapeutics Product
Table 73. Essentialis, Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 74. Essentialis, Inc. Recent Development
Table 75. Ferring International Center S.A. Company Details
Table 76. Ferring International Center S.A. Business Overview
Table 77. Ferring International Center S.A. Prader-Willi Syndrome Therapeutics Product
Table 78. Ferring International Center S.A. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 79. Ferring International Center S.A. Recent Development
Table 80. LG Life Sciences, Ltd. Company Details
Table 81. LG Life Sciences, Ltd. Business Overview
Table 82. LG Life Sciences, Ltd. Prader-Willi Syndrome Therapeutics Product
Table 83. LG Life Sciences, Ltd. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 84. LG Life Sciences, Ltd. Recent Development
Table 85. P2D Bioscience Company Details
Table 86. P2D Bioscience Business Overview
Table 87. P2D Bioscience Prader-Willi Syndrome Therapeutics Product
Table 88. P2D Bioscience Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 89. P2D Bioscience Recent Development
Table 90. Pfizer Inc. Company Details
Table 91. Pfizer Inc. Business Overview
Table 92. Pfizer Inc. Prader-Willi Syndrome Therapeutics Product
Table 93. Pfizer Inc. Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 94. Pfizer Inc. Recent Development
Table 95. Rhythm Pharmaceuticals Company Details
Table 96. Rhythm Pharmaceuticals Business Overview
Table 97. Rhythm Pharmaceuticals Prader-Willi Syndrome Therapeutics Product
Table 98. Rhythm Pharmaceuticals Revenue in Prader-Willi Syndrome Therapeutics Business (2016-2021) & (US$ Million)
Table 99. Rhythm Pharmaceuticals Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Prader-Willi Syndrome Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Beloranib Features
Figure 3. Betahistine Hydrochloride Features
Figure 4. Diazoxide Choline CR Features
Figure 5. FE-992097 Features
Figure 6. NOX-B11 Features
Figure 7. Others Features
Figure 8. Global Prader-Willi Syndrome Therapeutics Market Share by Application: 2020 VS 2027
Figure 9. Clinic Case Studies
Figure 10. Hospital Case Studies
Figure 11. Others Case Studies
Figure 12. Prader-Willi Syndrome Therapeutics Report Years Considered
Figure 13. Global Prader-Willi Syndrome Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 14. Global Prader-Willi Syndrome Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 15. Global Prader-Willi Syndrome Therapeutics Market Share by Regions: 2020 VS 2027
Figure 16. Global Prader-Willi Syndrome Therapeutics Market Share by Regions (2022-2027)
Figure 17. Global Prader-Willi Syndrome Therapeutics Market Share by Players in 2020
Figure 18. Global Top Prader-Willi Syndrome Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Prader-Willi Syndrome Therapeutics as of 2020
Figure 19. The Top 10 and 5 Players Market Share by Prader-Willi Syndrome Therapeutics Revenue in 2020
Figure 20. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type (2016-2021)
Figure 21. Global Prader-Willi Syndrome Therapeutics Revenue Market Share by Type (2022-2027)
Figure 22. North America Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. North America Prader-Willi Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 24. North America Prader-Willi Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 25. North America Prader-Willi Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 26. United States Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Canada Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 28. Europe Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. Europe Prader-Willi Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 30. Europe Prader-Willi Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 31. Europe Prader-Willi Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 32. Germany Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. France Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. U.K. Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Italy Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Russia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Nordic Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 38. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 40. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 41. Asia-Pacific Prader-Willi Syndrome Therapeutics Market Share by Region (2016-2027)
Figure 42. China Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Japan Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. South Korea Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Southeast Asia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. India Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Australia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 48. Latin America Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Latin America Prader-Willi Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 50. Latin America Prader-Willi Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 51. Latin America Prader-Willi Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 52. Mexico Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Brazil Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 54. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Share by Type (2016-2027)
Figure 56. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Share by Application (2016-2027)
Figure 57. Middle East & Africa Prader-Willi Syndrome Therapeutics Market Share by Country (2016-2027)
Figure 58. Turkey Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Saudi Arabia Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 60. UAE Prader-Willi Syndrome Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 61. Chong Kun Dang Pharmaceutical Corp. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2016-2021)
Figure 62. Essentialis, Inc. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2016-2021)
Figure 63. Ferring International Center S.A. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2016-2021)
Figure 64. LG Life Sciences, Ltd. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2016-2021)
Figure 65. P2D Bioscience Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2016-2021)
Figure 66. Pfizer Inc. Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2016-2021)
Figure 67. Rhythm Pharmaceuticals Revenue Growth Rate in Prader-Willi Syndrome Therapeutics Business (2016-2021)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed